# Editorial: lncRNAs: application in immunotherapy, radiotherapy, and chemotherapy

**Authors:** Huaifu Cheng, Ulf D. Kahlert, Wenjie Shi

PMC · DOI: 10.3389/fcell.2024.1438773 · Frontiers in Cell and Developmental Biology · 2024-07-25

## Full-text entities

- **Genes:** PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, HOTAIRM1 (HOXA transcript antisense RNA, myeloid-specific 1) [NCBI Gene 100506311] {aka HOXA-AS1, HOXA1-AS1, NCRNA00179}
- **Diseases:** non-small cell lung cancer (MESH:D002289), prostate cancer (MESH:D011471), gastric cancer (MESH:D013274), Parkinson's disease (MESH:D010300), ovarian cancer (MESH:D010051), lung cancer (MESH:D008175), Cancer (MESH:D009369), HCC (MESH:D006528), intervertebral disc degeneration (MESH:D055959), metastasis (MESH:D009362), sarcoma (MESH:D012509), glioblastoma (MESH:D005909), breast cancer (MESH:D001943)
- **Chemicals:** pembrolizumab (MESH:C582435), taxanes (MESH:D043823), platinum salts (-), tamoxifen (MESH:D013629), I-125 (MESH:C000614960)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11306187/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC11306187/full.md

---
Source: https://tomesphere.com/paper/PMC11306187